Vaccination of stage III/IV melanoma patients with long NY-ESO-1 peptide and CpG-B elicits robust CD8+ and CD4+ T-cell responses with multiple specificities including a novel DR7-restricted epitope

Details

Request a copyRequest a copy
Serval ID
serval:BIB_B9A2EC467477
Type
Article: article from journal or magazin.
Collection
Publications
Institution
UNIL/CHUV
Title
Vaccination of stage III/IV melanoma patients with long NY-ESO-1 peptide and CpG-B elicits robust CD8+ and CD4+ T-cell responses with multiple specificities including a novel DR7-restricted epitope
Journal
OncoImmunology
Author(s)
Baumgaertner P., Costa Nunes C., Cachot A., Maby-El Hajjami H., Cagnon L., Braun M., Derré L., Rivals J.-P., Rimoldi D., Gnjatic S., Abed Maillard S., Marcos Mondéjar P., Protti M. P., Romano E., Michielin O., Romero P., Speiser D. E., Jandus C.
ISSN
2162-402X
Publication state
Published
Issued date
02/10/2016
Volume
5
Number
10
Pages
e1216290
Language
english
OAI-PMH
oai:serval.unil.ch:BIB_B9A2EC467477
DOI
10.1080/2162402x.2016.1216290
Pubmed
27853637
Web of science
000387271300006
Open Access
Yes
Create date
01/04/2020 13:40
Last modification date
07/04/2021 5:34
Usage data